Participants received once-weekly subcutaneous semaglutide 2.4 mg (n = 47) or placebo (n = 24)
Note that before you start making herbal suppositories for a specific purpose, it is important to have your symptoms evaluated and diagnosed by a certified health professional
FDA Commissioner Marty Makary put it directly: "When FDA-approved drugs are available, outsourcing facilities cannot lawfully compound using bulk drug substances unless there is a clear clinical need." [1] The proposal is open for public comment through June 29, 2026
Read more about it here: #GLP1 To view or add a comment, sign in Earlier this month the FDA announced the establishment of a "green list" import alert for GLP-1s designed to prevent unverified GLP-1 active pharmaceutical ingredients from entering the United States
Rare Allergic Reactions Though rare, some individuals may be sensitive to the sulfur content in glutathione
The product is intended exclusively for scientific and research purposes